Annual EBITDA
-$821.29 M
+$1.26 B+60.46%
December 31, 2023
Summary
- As of February 22, 2025, DNA annual EBITDA is -$821.29 million, with the most recent change of +$1.26 billion (+60.46%) on December 31, 2023.
- During the last 3 years, DNA annual EBITDA has fallen by -$712.71 million (-656.36%).
- DNA annual EBITDA is now -670.02% below its all-time high of -$106.66 million, reached on December 31, 2019.
Performance
DNA EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$35.09 M
+$105.61 M+75.06%
September 30, 2024
Summary
- As of February 22, 2025, DNA quarterly EBITDA is -$35.09 million, with the most recent change of +$105.61 million (+75.06%) on September 30, 2024.
- Over the past year, DNA quarterly EBITDA has increased by +$253.80 million (+87.85%).
- DNA quarterly EBITDA is now -90.76% below its all-time high of -$18.39 million, reached on September 30, 2021.
Performance
DNA Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$629.79 M
+$134.04 M+17.55%
September 30, 2024
Summary
- As of February 22, 2025, DNA TTM EBITDA is -$629.79 million, with the most recent change of +$134.04 million (+17.55%) on September 30, 2024.
- Over the past year, DNA TTM EBITDA has increased by +$191.50 million (+23.32%).
- DNA TTM EBITDA is now -2367.07% below its all-time high of -$25.53 million, reached on September 30, 2020.
Performance
DNA TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
DNA EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +60.5% | +87.8% | +23.3% |
| 3 y3 years | -656.4% | +87.8% | +23.3% |
| 5 y5 years | -670.0% | -37.4% | -2367.1% |
DNA EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +60.5% | at high | +97.9% | at high | +82.7% |
| 5 y | 5-year | -670.0% | +60.5% | -90.8% | +97.9% | -2367.1% | +82.7% |
| alltime | all time | -670.0% | +60.5% | -90.8% | +97.9% | -2367.1% | +82.7% |
Ginkgo Bioworks Holdings EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$35.09 M(-75.1%) | -$629.79 M(-17.5%) |
| Jun 2024 | - | -$140.69 M(-14.8%) | -$763.83 M(-3.3%) |
| Mar 2024 | - | -$165.13 M(-42.8%) | -$789.64 M(-3.9%) |
| Dec 2023 | -$821.29 M(-60.5%) | -$288.88 M(+70.8%) | -$821.29 M(+24.8%) |
| Sep 2023 | - | -$169.12 M(+1.6%) | -$658.08 M(-42.1%) |
| Jun 2023 | - | -$166.50 M(-15.4%) | -$1.14 B(-29.3%) |
| Mar 2023 | - | -$196.79 M(+56.6%) | -$1.61 B(-22.6%) |
| Dec 2022 | -$2.08 B | -$125.67 M(-80.6%) | -$2.08 B(-42.9%) |
| Sep 2022 | - | -$647.02 M(+1.5%) | -$3.64 B(+20.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | -$637.75 M(-4.3%) | -$3.01 B(+24.2%) |
| Mar 2022 | - | -$666.43 M(-60.4%) | -$2.42 B(+32.8%) |
| Dec 2021 | -$1.81 B(+1563.8%) | -$1.68 B(+9055.7%) | -$1.82 B(+903.3%) |
| Sep 2021 | - | -$18.39 M(-65.2%) | -$181.80 M(-3.8%) |
| Jun 2021 | - | -$52.78 M(-23.3%) | -$188.94 M(+38.8%) |
| Mar 2021 | - | -$68.83 M(+64.7%) | -$136.16 M(+102.2%) |
| Dec 2020 | -$108.58 M(+1.8%) | -$41.80 M(+63.7%) | -$67.33 M(+163.7%) |
| Sep 2020 | - | -$25.53 M | -$25.53 M |
| Dec 2019 | -$106.66 M | - | - |
FAQ
- What is Ginkgo Bioworks Holdings annual EBITDA?
- What is the all time high annual EBITDA for Ginkgo Bioworks Holdings?
- What is Ginkgo Bioworks Holdings annual EBITDA year-on-year change?
- What is Ginkgo Bioworks Holdings quarterly EBITDA?
- What is the all time high quarterly EBITDA for Ginkgo Bioworks Holdings?
- What is Ginkgo Bioworks Holdings quarterly EBITDA year-on-year change?
- What is Ginkgo Bioworks Holdings TTM EBITDA?
- What is the all time high TTM EBITDA for Ginkgo Bioworks Holdings?
- What is Ginkgo Bioworks Holdings TTM EBITDA year-on-year change?
What is Ginkgo Bioworks Holdings annual EBITDA?
The current annual EBITDA of DNA is -$821.29 M
What is the all time high annual EBITDA for Ginkgo Bioworks Holdings?
Ginkgo Bioworks Holdings all-time high annual EBITDA is -$106.66 M
What is Ginkgo Bioworks Holdings annual EBITDA year-on-year change?
Over the past year, DNA annual EBITDA has changed by +$1.26 B (+60.46%)
What is Ginkgo Bioworks Holdings quarterly EBITDA?
The current quarterly EBITDA of DNA is -$35.09 M
What is the all time high quarterly EBITDA for Ginkgo Bioworks Holdings?
Ginkgo Bioworks Holdings all-time high quarterly EBITDA is -$18.39 M
What is Ginkgo Bioworks Holdings quarterly EBITDA year-on-year change?
Over the past year, DNA quarterly EBITDA has changed by +$253.80 M (+87.85%)
What is Ginkgo Bioworks Holdings TTM EBITDA?
The current TTM EBITDA of DNA is -$629.79 M
What is the all time high TTM EBITDA for Ginkgo Bioworks Holdings?
Ginkgo Bioworks Holdings all-time high TTM EBITDA is -$25.53 M
What is Ginkgo Bioworks Holdings TTM EBITDA year-on-year change?
Over the past year, DNA TTM EBITDA has changed by +$191.50 M (+23.32%)